Skip to content

Study to Assess the Clinical Efficacy of the Specialized Enteral Tube Nutrition Composition Nutrison Advanced Cubison as a Part of Complex Pressure Ulcers (PU) Therapy

Prospective Multicenter Randomized Controlled Low-interventional Post-registration Study to Assess the Clinical Efficacy of the Specialized Enteral Tube Nutrition Composition Nutrison Advanced Cubison as a Part of Complex Pressure Ulcers (PU) Therapy Versus Standard Enteral Tube Nutrition Products

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05461911
Enrollment
60
Registered
2022-07-18
Start date
2021-06-01
Completion date
2021-12-01
Last updated
2022-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure Ulcer ( Stage 2-3)

Keywords

Stroke, Traumatic Brain Injury

Brief summary

A large number of studies are devoted to studying the effect of patient nutrition on the occurrence and treatment of pressure ulcers. Several studies, including the US National Long-term Treatment of Pressure Ulcers Study, have shown that weight loss and malnutrition were associated with a higher risk of pressure ulcers. One of the successful products specially created for the treatment of pressure ulcers and taking into account the results of research is the high-protein, energy-rich, ready-to-use enteral tube feeding food product Nutrison Advanced Cubison. It is a complete enteral nutritional supplement with an innovative nutrient composition for patients with chronic wounds, including pressure ulcers, or at increased risk of developing them. Taking into account the available data, it seems expedient to continue studying the unique combination of nutrients that make up the study food product Nutrison Advanced Cubison in order to develop the most effective nutritional protocols for patients at risk for the treatment and prevention of pressure ulcers.

Interventions

DIETARY_SUPPLEMENTNutrison Advanced Cubison

(20% protein energy 100 kcal, 5.5 g protein, 0.85 g arginine, 38 mg of vitamin C and 2 mg of zinc) in a volume not exceeding 1.5 liters / day and, if necessary, to replenish nutritional needs based on the total daily intake of 30-35 kcal / kg / day and 1.2-1.5 g of protein / kg body weight / day according to the recommendations for nutritional support

Sponsors

Danone Nutricia
CollaboratorINDUSTRY
Enrollme.ru, LLC
Lead SponsorNETWORK

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with stroke / TBI and who are on tube feeding * Presence of pressure ulcers of 2-3 stages * Informed voluntary consent to medical intervention is formalized in accordance with the requirements of the Federal Law of 21.11.2011 N 323-FZ On the basics of protecting the health of citizens in the Russian Federation.

Exclusion criteria

* Hemodynamically unstable patients * Severe renal impairment (GFR \<30 ml / min) * Moderate or severe liver failure (Child-Pugh Class B or C) * Oncological diseases (lasting more than 5 years) * Hypersensitivity to any component of the test food mixture * Inclusion in clinical interventional research * Uncertainty of the investigator about the willingness or ability of the subject to comply with the protocol requirements * Any other medical or non-medical reasons that, in the opinion of the physician, may prevent the patient from participating in the study

Design outcomes

Primary

MeasureTime frameDescription
Changes in the area of pressure ulcers in both groups during the studyup to 4 weeks
The proportion of patients in both groups with a decrease in the area of the pressure ulcer by 20% or more by the date of completion of observationsup to 4 weeks
Changes in the Pressure Ulcer Scale for Healing values in both groups during the studyup to 4 weeksPressure Ulcer Scale for Healing (PUSH) is a common tool to monitor pressure healing over time. The PUSH Tool monitors three parameters: surface area of the wound, wound exudate and type of wound tissue. Minimum value is 0, maximum value is 17. The bigger scale is the worse

Secondary

MeasureTime frame
Concentration of the blood lymphocytes at the beginning and at the end of observationsup to 4 weeks
Duration of treatment for pressure ulcers in study patientsup to 4 weeks
Concentration of the C-reactive protein at the beginning and at the end of observationsup to 4 weeks
Frequency and duration of infectious complications of pressure ulcers in study patientsup to 4 weeks
Concentration of the blood albumin at the beginning and at the end of observationsup to 4 weeks

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026